Literature DB >> 25733263

Does hypertension impact 24-hour urine parameters in patients with nephrolithiasis?

Christopher Hartman1, Justin I Friedlander2, Daniel M Moreira3, David A Leavitt3, David M Hoenig3, Arthur D Smith3, Zeph Okeke3.   

Abstract

OBJECTIVE: To examine the differences in 24-hour urine parameters and stone composition between patients with and without systemic hypertension (HTN) in a large cohort of stone formers.
MATERIALS AND METHODS: We performed a retrospective review over a 10-year period of patients with stone, who had completed a 24-hour urinalysis (Litholink) and for whom demographic information was available, including the presence of HTN. Univariate and multivariate analyses were performed, comparing the 24-hour urinalysis profiles of patients with HTN with that of normotensive patients.
RESULTS: Of the 1115 patients eligible for inclusion, 442 patients (40%) had HTN and 673 (60%) did not. Patients with HTN were significantly older, had a higher body mass index, and had a greater number of comorbid conditions than normotensive patients. Univariate analysis revealed significantly lower urine pH, calcium, supersaturation (SS) of calcium oxalate (CaOx) and SS calcium phosphate (all P <.05) in patients with HTN. Multivariate analysis showed significantly lower calcium, citrate, and SS CaOx in patients with HTN (all P <.05).
CONCLUSION: Our results demonstrate lower levels of calcium and SS CaOx on univariate and multivariate analysis, as well as lower levels of citrate on multivariate analysis in patients with HTN. These results suggest that lower levels of citrate may contribute to stone formation to a greater degree in patients with HTN than abnormalities in calcium metabolism.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2015        PMID: 25733263     DOI: 10.1016/j.urology.2014.12.013

Source DB:  PubMed          Journal:  Urology        ISSN: 0090-4295            Impact factor:   2.649


  7 in total

1.  The impact of body mass index on quantitative 24-h urine chemistries in stone forming patients: a systematic review and meta-analysis.

Authors:  Qing Wang; Weijie Hu; Yuchao Lu; Henglong Hu; Jiaqiao Zhang; Shaogang Wang
Journal:  Urolithiasis       Date:  2018-02-08       Impact factor: 3.436

2.  Association between hypertension and 24-h urine composition in adults without urolithiasis in China.

Authors:  Tuo Deng; Zanlin Mai; Xiaolu Duan; Zhijian Zhao; Wei Zhu; Chao Cai; Wenqi Wu; Guohua Zeng
Journal:  World J Urol       Date:  2020-04-06       Impact factor: 4.226

3.  Systemic Succinate Homeostasis and Local Succinate Signaling Affect Blood Pressure and Modify Risks for Calcium Oxalate Lithogenesis.

Authors:  Ahlam Khamaysi; Shireen Anbtawee-Jomaa; Moran Fremder; Hadar Eini-Rider; Liana Shimshilashvili; Sara Aharon; Elina Aizenshtein; Tomer Shlomi; Audrey Noguchi; Danielle Springer; Orson W Moe; Nikolay Shcheynikov; Shmuel Muallem; Ehud Ohana
Journal:  J Am Soc Nephrol       Date:  2019-02-06       Impact factor: 10.121

4.  Impact of Demographic Factors and Systemic Disease on Urinary Stone Risk Parameters Amongst Stone Formers.

Authors:  Kyle Wood; Carter Boyd; Dustin Whitaker; Omotola Ashorobi; William Poore; Barbara Gower; Dean G Assimos
Journal:  Rev Urol       Date:  2019

5.  Association between metabolic syndrome and calcium oxalate stone risk in Chinese individuals: a nomogram prediction model.

Authors:  Baisuo Wu; Junhao Xie; Junyi Guo; Jinbo Wang; Hongjuan Lang
Journal:  J Int Med Res       Date:  2021-02       Impact factor: 1.671

Review 6.  Nephrolithiasis: A Red Flag for Cardiovascular Risk.

Authors:  Alessia Gambaro; Gianmarco Lombardi; Chiara Caletti; Flavio Luciano Ribichini; Pietro Manuel Ferraro; Giovanni Gambaro
Journal:  J Clin Med       Date:  2022-09-20       Impact factor: 4.964

7.  Influence of weight status on 24-hour urine composition in adults without urolithiasis: A nationwide study based on a Chinese Han population.

Authors:  Tuo Deng; Zanlin Mai; Chao Cai; Xiaolu Duan; Wei Zhu; Tao Zhang; Wenqi Wu; Guohua Zeng
Journal:  PLoS One       Date:  2017-09-08       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.